Neurochemical changes in the aging human brain: Implications for behavioral impairment and neurodegenerative disease

Geriatrics

Volumn 53, Issue 1 SUPPL., 1998, Pages

  Strong, Randy ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROTRANSMITTER;

ACETYLCHOLINE BRAIN LEVEL; AGED; AGING; BRAIN FUNCTION; DEGENERATIVE DISEASE; DEPRESSION; DISEASE PREDISPOSITION; DOPAMINE BRAIN LEVEL; HUMAN; MEMORY; MOOD; MOTOR PERFORMANCE; NERVE DEGENERATION; PARKINSON DISEASE; PATHOPHYSIOLOGY; REVIEW; SEROTONIN BRAIN LEVEL;

AGING; ANIMALS; BRAIN; HUMANS; MENTAL DISORDERS; NEURODEGENERATIVE DISEASES; NEUROTRANSMITTER AGENTS;

EID: 0031709338     PISSN: 0016867X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (2)

1. Strong R, Wood WG, Samorajski T. Neurochemistry of aging. In: Pathy MSJ, ed. Principles and practice of geriatric medicine. 2nd ed. New York: John Wiley & Sons, 1991:69-97.
2. DeKosky ST, Palmer AM. Neurochemistry of aging. In: Albert ML, Knoefel JE, eds. Clinical neurology of aging. 2nd ed. New York: Oxford University Press, 1994:79-101.